William J. Febbo

William J. Febbo

Former Chief Executive OfficeratOptimizeRx· In proxies 2023–2024

Pay in FY2024-19% from the year before · OptimizeRx stock -66.0% the same year

William J. Febbo was paid $2.3M in FY2024 (Dec), down 19%. OptimizeRx stock fell 66.0% that year.

Pay$100 in the stock at the end of FY22 → $29
Pay is from the Summary Compensation Table of each OptimizeRx proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. OptimizeRxPublic company · 3 yr
    • Former Chief Executive Officer2023 – Present · 3 yrStock in role -42%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?